Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jose Romero

Concepts (173)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Small Vessel Diseases
6
2024
7
3.880
Why?
Stroke
13
2023
493
2.870
Why?
Dementia
3
2024
143
2.230
Why?
Cerebral Hemorrhage
9
2023
104
1.220
Why?
Magnetic Resonance Imaging
14
2023
1541
1.210
Why?
Brain
8
2023
1328
0.910
Why?
Alzheimer Disease
2
2022
317
0.790
Why?
Cerebral Amyloid Angiopathy
4
2023
4
0.730
Why?
Hypertension
2
2020
537
0.520
Why?
Thrombolytic Therapy
3
2020
110
0.510
Why?
Longitudinal Studies
6
2022
695
0.470
Why?
Humans
38
2024
50208
0.460
Why?
Brain Ischemia
3
2020
161
0.430
Why?
Risk Factors
13
2023
3629
0.420
Why?
Tick-Borne Diseases
1
2012
6
0.410
Why?
Aged
16
2023
9405
0.380
Why?
Parechovirus
1
2011
2
0.380
Why?
Anti-Bacterial Agents
3
2017
747
0.380
Why?
Viral Vaccines
1
2011
12
0.370
Why?
Picornaviridae Infections
1
2011
18
0.370
Why?
Respiratory Syncytial Virus Infections
1
2010
36
0.370
Why?
Antibodies, Viral
1
2011
88
0.360
Why?
Respiratory Sounds
1
2010
48
0.360
Why?
RNA, Viral
1
2011
126
0.360
Why?
Respiratory Tract Infections
1
2010
76
0.350
Why?
Infant, Premature, Diseases
1
2010
94
0.340
Why?
Male
21
2023
25399
0.340
Why?
Female
22
2023
26635
0.340
Why?
Genome-Wide Association Study
3
2023
166
0.320
Why?
Pneumonia, Viral
2
2020
169
0.290
Why?
Coronavirus Infections
2
2020
178
0.280
Why?
Tissue Plasminogen Activator
3
2021
109
0.260
Why?
Cohort Studies
7
2021
1422
0.260
Why?
Motor Cortex
2
2002
13
0.250
Why?
Chromosomes, Human, Pair 10
1
2023
3
0.230
Why?
Incidence
6
2021
1006
0.230
Why?
Basal Ganglia
1
2023
26
0.220
Why?
Middle Aged
11
2022
12206
0.210
Why?
Infarction
1
2022
14
0.210
Why?
Fibrinolytic Agents
2
2021
125
0.210
Why?
Plaque, Atherosclerotic
1
2022
38
0.210
Why?
Carotid Stenosis
1
2022
64
0.200
Why?
Electromagnetic Fields
1
2002
16
0.200
Why?
Mental Health
1
2024
220
0.200
Why?
Early Medical Intervention
1
2020
8
0.180
Why?
Sinus Thrombosis, Intracranial
1
2020
17
0.180
Why?
Ischemic Attack, Transient
1
2021
56
0.180
Why?
Image Interpretation, Computer-Assisted
1
2021
106
0.180
Why?
Atherosclerosis
1
2023
214
0.180
Why?
Asymptomatic Diseases
1
2020
36
0.180
Why?
Cardiovascular Diseases
2
2023
443
0.180
Why?
Iron
1
2021
122
0.180
Why?
Neurology
1
2020
40
0.180
Why?
Data Interpretation, Statistical
1
2020
157
0.170
Why?
Radiography, Interventional
1
2020
57
0.170
Why?
Societies, Medical
1
2020
177
0.170
Why?
tau Proteins
1
2019
26
0.170
Why?
Venous Thrombosis
1
2020
90
0.170
Why?
Aged, 80 and over
7
2021
3154
0.170
Why?
Needs Assessment
1
2020
133
0.170
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2020
138
0.170
Why?
Recombinant Fusion Proteins
1
2010
186
0.170
Why?
Risk Assessment
2
2020
1262
0.160
Why?
Health Services Needs and Demand
1
2020
158
0.160
Why?
Angiogenesis Inhibitors
1
2010
188
0.160
Why?
Papillomavirus Vaccines
1
2019
61
0.150
Why?
Pneumococcal Vaccines
1
2017
8
0.150
Why?
Pharmacies
1
2019
61
0.150
Why?
Community Pharmacy Services
1
2019
67
0.150
Why?
Pneumococcal Infections
1
2017
8
0.150
Why?
Streptococcus pneumoniae
1
2017
22
0.150
Why?
Endovascular Procedures
1
2020
174
0.150
Why?
Arthritis, Infectious
1
2017
45
0.150
Why?
Stroke, Lacunar
1
2016
1
0.140
Why?
Prevalence
1
2020
951
0.140
Why?
Papillomavirus Infections
1
2019
155
0.140
Why?
Emotions
1
2017
164
0.140
Why?
Osteomyelitis
1
2017
126
0.140
Why?
Antibodies, Monoclonal
1
2010
460
0.130
Why?
Retrospective Studies
6
2022
6134
0.130
Why?
Ovarian Neoplasms
1
2010
447
0.130
Why?
United States
5
2020
4874
0.120
Why?
Stenotrophomonas maltophilia
1
2014
6
0.120
Why?
Gram-Negative Bacterial Infections
1
2014
39
0.120
Why?
Leptin
1
2015
140
0.120
Why?
Meningitis, Meningococcal
1
2013
3
0.110
Why?
Meningococcal Infections
1
2013
4
0.110
Why?
Child, Preschool
4
2020
3883
0.110
Why?
RNA-Directed DNA Polymerase
1
2002
6
0.110
Why?
Oligodeoxyribonucleotides
1
2002
29
0.110
Why?
Infant
4
2017
3563
0.100
Why?
Bacteremia
1
2013
92
0.100
Why?
Evoked Potentials, Motor
2
2002
7
0.100
Why?
Neutrophils
1
2013
148
0.100
Why?
Amyloid beta-Peptides
2
2023
65
0.100
Why?
DNA, Complementary
1
2002
135
0.100
Why?
Tularemia
1
2012
21
0.100
Why?
Ehrlichiosis
1
2012
15
0.100
Why?
Lyme Disease
1
2012
32
0.100
Why?
Brain Infarction
2
2022
12
0.100
Why?
Antineoplastic Agents
1
2010
1186
0.100
Why?
Pandemics
3
2020
562
0.100
Why?
Upper Extremity Deep Vein Thrombosis
1
2011
3
0.100
Why?
Embolism, Paradoxical
1
2011
3
0.090
Why?
Intracranial Embolism
1
2011
27
0.090
Why?
Foramen Ovale, Patent
1
2011
27
0.090
Why?
Administration, Intravenous
2
2020
68
0.090
Why?
Mycobacterium tuberculosis
1
2002
285
0.090
Why?
Adult
6
2021
13324
0.080
Why?
Massachusetts
2
2019
25
0.080
Why?
Prospective Studies
3
2020
2379
0.080
Why?
Anticoagulants
2
2021
253
0.080
Why?
Infant, Premature
1
2010
319
0.070
Why?
Severity of Illness Index
1
2010
951
0.070
Why?
Infant, Newborn
2
2014
2766
0.070
Why?
Cross-Sectional Studies
2
2023
1554
0.070
Why?
Arkansas
1
2012
1985
0.070
Why?
Treatment Outcome
3
2020
5155
0.060
Why?
Child
4
2020
6851
0.060
Why?
Case-Control Studies
2
2020
1126
0.060
Why?
Young Adult
3
2020
3981
0.060
Why?
Electromyography
2
2002
131
0.060
Why?
Methyltransferases
1
2023
29
0.060
Why?
Constriction, Pathologic
1
2022
96
0.050
Why?
Carotid Arteries
1
2022
85
0.050
Why?
Adolescent
3
2020
6390
0.050
Why?
Antihypertensive Agents
1
2023
121
0.050
Why?
Nerve Net
1
2002
69
0.050
Why?
Genomics
1
2023
285
0.050
Why?
Endothelial Cells
1
2023
270
0.050
Why?
Polymorphism, Single Nucleotide
1
2023
485
0.050
Why?
Atrophy
1
2020
38
0.050
Why?
Neuroimaging
1
2021
85
0.050
Why?
Polysomnography
1
2020
71
0.050
Why?
Genetic Predisposition to Disease
1
2023
509
0.050
Why?
Boston
1
2020
11
0.050
Why?
Endocrine System Diseases
1
2010
10
0.040
Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
22
0.040
Why?
Fluid Therapy
1
2020
75
0.040
Why?
Critical Pathways
1
2020
39
0.040
Why?
Vascular Diseases
1
2020
74
0.040
Why?
Triage
1
2020
62
0.040
Why?
Thrombectomy
1
2020
67
0.040
Why?
Brain Mapping
1
2020
235
0.040
Why?
Skin Diseases
1
2010
111
0.040
Why?
Gastrointestinal Diseases
1
2010
126
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2010
225
0.040
Why?
Pharmacists
1
2019
144
0.040
Why?
Drug Resistance, Bacterial
1
2017
71
0.040
Why?
Sensitivity and Specificity
1
2019
863
0.040
Why?
Vaccination
1
2019
271
0.040
Why?
Pilot Projects
1
2019
697
0.030
Why?
Microbial Sensitivity Tests
1
2017
270
0.030
Why?
Waist-Hip Ratio
1
2015
6
0.030
Why?
Reproducibility of Results
1
2019
1185
0.030
Why?
Radioimmunoassay
1
2015
44
0.030
Why?
Clavulanic Acids
1
2014
8
0.030
Why?
Ticarcillin
1
2014
8
0.030
Why?
Proportional Hazards Models
1
2015
410
0.030
Why?
Neisseria meningitidis
1
2013
5
0.030
Why?
Time Factors
1
2020
2922
0.030
Why?
Leukocyte Count
1
2013
72
0.030
Why?
Intensive Care Units
1
2014
222
0.030
Why?
Predictive Value of Tests
1
2015
905
0.030
Why?
DNA Primers
1
2002
207
0.030
Why?
Transcription, Genetic
1
2002
369
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2002
411
0.020
Why?
Gene Expression Regulation, Bacterial
1
2002
191
0.020
Why?
RNA, Messenger
1
2002
1108
0.020
Why?
Prognosis
1
2013
1954
0.020
Why?
Electric Stimulation
1
2002
118
0.010
Why?
Transcranial Magnetic Stimulation
1
2002
70
0.010
Why?
Cerebral Cortex
1
2002
200
0.010
Why?
Romero's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description